Ahmed Kaid Alantry
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ahmed Kaid Alantry has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Elsayed A. Elmorsy
Department of Pharmacology and Toxicology, College of Pharmacy, Qassim University, Buraidah 52571, Saudi Arabia; Department of Clinical Pharmacology, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt
2 shared publications - Hamad Alsaykhan
Department of Anatomy and Histology, College of Medicine, Qassim University, Buraidah 51452, Saudi Arabia
2 shared publications - Mostafa M. Khodeir
Department of Pathology, College of medicine, Qassim University, Buraidah, Saudi Arabia
2 shared publications - Sameh Saber
Department of Pharmacology, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, 11152, Egypt
2 shared publications - Abdel-Rahman Youssef
Division of Basic Medical Sciences, College of Dental Medicine, Umm Al-Qura University, Makkah, Saudi Arabia
1 shared publication - Abdelrahman El-Sayed
Faculty of Medicine, Damietta University, New Damietta 34517, Egypt
1 shared publication
Latest Publications
- Open Access
- 17 October 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (20) , 9227
The Genetic Landscape of Pompe Disease in the Middle East, North Africa, and Turkey (MENAT Region): A Systematic Review of GAA Variants and Genotype–Phenotype Correlation
Pompe disease is a rare autosomal recessive multisystem disorder caused by pathogenic variants in the acid alpha-glucosidase (GAA) gene, resulting in lysosomal glycogen accumulation and a broad clinical spectrum ranging from rapidly fatal infantile-onset disease (IOPD) to slowly progressive late-onset Pompe disease (LOPD). The genetic epidemiology of Pompe disease across the Middle East, North Africa, and Turkey (MENAT) region remains poorly characterized despite high regional rates of consanguinity. We systematically searched PubMed, ScienceDirect, Google Scholar, and Scopus from inception to July 2026 for studies reporting GAA variants in patients with Pompe disease from MENAT countries, following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. We included 24 studies comprising 134 patients with Pompe disease, identifying 61 distinct GAA variants. Twelve variants were unique to the MENAT region. Missense variants were the most common variant type, accounting for 50.8% of all distinct variants, followed by frameshift variants 19.7%. Egypt contributed the largest number of reported patients (24/134, 17.9%) followed by Saudi Arabia, Iran, and Iraq (18/134, 13.4%) for each country. The most prevalent variant across the MENAT region is the leaky intronic splice-site variant c.-32-13T>G, reported in 11.2% of all patients and in cases from Turkey, Algeria, Iran and Egypt. Of the 61 distinct variants, 35 were associated with IOPD and 24 with LOPD, with c.1064T>C (p.Leu355Pro) and c.2104C>T (p.Arg702Cys) reported in association with both phenotypes. This systematic review identified country-specific variants in the MENAT region related to Pompe disease that are distinct from other reported variants worldwide. Further studies with larger sample sizes are needed to comprehend the genotype–phenotype correlation for Pompe disease in the MENAT region.
- 17 October 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (20) , 9227
Open AccessThe Genetic Landscape of Pompe Disease in the Middle East, North Africa, and Turkey (MENAT Region): A Systematic Review of GAA Variants and Genotype–Phenotype Correlation
Pompe disease is a rare autosomal recessive multisystem disorder caused by pathogenic variants in the acid alpha-glucosidase (GAA) gene, resulting in lysosomal glycogen accumulation and a broad clinical spectrum ranging from rapidly fatal infantile-onset disease (IOPD) to slowly progressive late-onset Pompe disease (LOPD). The genetic epidemiology of Pompe disease across the Middle East, North Africa, and Turkey (MENAT) region remains poorly characterized despite high regional rates of consanguinity. We systematically searched PubMed, ScienceDirect, Google Scholar, and Scopus from inception to July 2026 for studies reporting GAA variants in patients with Pompe disease from MENAT countries, following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. We included 24 studies comprising 134 patients with Pompe disease, identifying 61 distinct GAA variants. Twelve variants were unique to the MENAT region. Missense variants were the most common variant type, accounting for 50.8% of all distinct variants, followed by frameshift variants 19.7%. Egypt contributed the largest number of reported patients (24/134, 17.9%) followed by Saudi Arabia, Iran, and Iraq (18/134, 13.4%) for each country. The most prevalent variant across the MENAT region is the leaky intronic splice-site variant c.-32-13T>G, reported in 11.2% of all patients and in cases from Turkey, Algeria, Iran and Egypt. Of the 61 distinct variants, 35 were associated with IOPD and 24 with LOPD, with c.1064T>C (p.Leu355Pro) and c.2104C>T (p.Arg702Cys) reported in association with both phenotypes. This systematic review identified country-specific variants in the MENAT region related to Pompe disease that are distinct from other reported variants worldwide. Further studies with larger sample sizes are needed to comprehend the genotype–phenotype correlation for Pompe disease in the MENAT region.
- Open Access
Synthesis and Spectroscopic Characterization of Benzimidazole-Derived Schiff Base: Investigation of Optical Properties, DNA Binding, DFT, and Molecular Docking
This study reports the synthesis and characterization of a novel benzimidazole-derived Schiff base (BIMPB) via the condensation of (1H-benzo[d]imidazol-2-yl)methanamine with 1-phenylbutane-1,3-dione. The structure was confirmed using 1H-NMR, 13C-NMR and FT-IR spectroscopy. Photophysical properties were extensively evaluated, revealing a strong S0 → S2 transition at 212 nm and fluorescence emission peaks at 396 and 410 nm, corresponding to π → π* and n → π* transitions. BIMPB demonstrated significant sensitivity to pH variations, exhibiting blue shifts of 11–23 nm across different environments. Furthermore, the compound acts as a fluorescent chemosensor for Cu2+ and Ca2+ ions, where coordination leads to a substantial reduction in fluorescence intensity accompanied by a distinct blue shift. The interaction between BIMPB and DNA was investigated using UV-Vis and fluorescence titration. The results showed a hypochromic effect and a minor shift in the absorption peak from 342 nm to 340 nm, suggesting a binding mechanism dominated by intercalation or electrostatic interactions. A high binding constant (Kb = 2.1 × 105 M−1) and a fluorescence quenching efficiency of 58.9% confirm the formation of a stable complex. Stern–Volmer analysis indicated a static quenching mechanism. These experimental findings, supported by molecular docking studies (binding energy = −8.3 kcal/mol), highlight the potential of BIMPB as a sensitive molecular probe for DNA-targeting and chemical sensing applications.
Open AccessSynthesis and Spectroscopic Characterization of Benzimidazole-Derived Schiff Base: Investigation of Optical Properties, DNA Binding, DFT, and Molecular Docking
This study reports the synthesis and characterization of a novel benzimidazole-derived Schiff base (BIMPB) via the condensation of (1H-benzo[d]imidazol-2-yl)methanamine with 1-phenylbutane-1,3-dione. The structure was confirmed using 1H-NMR, 13C-NMR and FT-IR spectroscopy. Photophysical properties were extensively evaluated, revealing a strong S0 → S2 transition at 212 nm and fluorescence emission peaks at 396 and 410 nm, corresponding to π → π* and n → π* transitions. BIMPB demonstrated significant sensitivity to pH variations, exhibiting blue shifts of 11–23 nm across different environments. Furthermore, the compound acts as a fluorescent chemosensor for Cu2+ and Ca2+ ions, where coordination leads to a substantial reduction in fluorescence intensity accompanied by a distinct blue shift. The interaction between BIMPB and DNA was investigated using UV-Vis and fluorescence titration. The results showed a hypochromic effect and a minor shift in the absorption peak from 342 nm to 340 nm, suggesting a binding mechanism dominated by intercalation or electrostatic interactions. A high binding constant (Kb = 2.1 × 105 M−1) and a fluorescence quenching efficiency of 58.9% confirm the formation of a stable complex. Stern–Volmer analysis indicated a static quenching mechanism. These experimental findings, supported by molecular docking studies (binding energy = −8.3 kcal/mol), highlight the potential of BIMPB as a sensitive molecular probe for DNA-targeting and chemical sensing applications.
- Open Access
- 30 September 2025
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 214, 107302
Activation of nicotinamide phosphoribosyltransferase protects against unilateral renal ischemia-reperfusion injury via the NAD+/SIRT1/PGC-1α signaling pathway and modulation of NFκB/TNF-α/IL-6
- 30 September 2025
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 214, 107302
Open AccessActivation of nicotinamide phosphoribosyltransferase protects against unilateral renal ischemia-reperfusion injury via the NAD+/SIRT1/PGC-1α signaling pathway and modulation of NFκB/TNF-α/IL-6